# The TauTona Group

The TauTona Group is a Private Equity based in Redwood City, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Redwood City, United States
- **Region:** North America
- **Address:** Redwood City, CA, United States
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** tautonagroup.com
- **LinkedIn:** https://www.linkedin.com/company/tautona-group

## Regulatory record

- **CRD number:** 285063
- **SEC file number:** 802-108361
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/285063

## About

TauTona Group is a vertically-integrated operational fund that creates, invests and develops new solutions in medtech, biotech and regenerative medicine that address unmet clinical needs in healthcare. Its sustainable investment model enables disruptive ideas to be evaluated, designed, tested and developed in an extremely economic manner. The fund was founded in 2010 by two Stanford School of Medicine professors and researchers focused on bioengineering, tissue regeneration, and stem cell therapeutic approaches.

## Sectors

- medtech, biotech and regenerative medicine

## People

- Geoffrey C. Gurtner — MD — Co-Founder & Managing Partner
- Michael Longaker — MD — Co-Founder and General Partner
- Mike Blanchette — Chief Operating Officer
- Kellen Chen — Head of Research
- Susan Hale — Head of Quality and Regulatory
- Marta Bulaich — Marketing Development
- Geoffrey C. Gurtner — MD — Co-Founder & Managing Partner
- Michael Longaker — MD — Co-Founder and General Partner
- Mike Blanchette — Chief Operating Officer
- Marta Bulaich — Marketing Development

## Questions

### What is the TauTona Group's investment strategy?

TauTona pursues a hybrid strategy combining corporate divestitures and spin-offs with early-stage venture investing. The firm acquires orphaned business units, product lines, and subsidiaries from corporate parents while simultaneously writing seed and start-up checks to new companies. This dual-track approach is an outlier in a private equity market where most firms segregate buyout and venture activities into separate funds.

## Related profiles

- [The Taken Seat](https://altss.com/profile/the-taken-seat)
- [The Techshop](https://altss.com/profile/the-techshop)

---

Last updated: 2026-08-11T15:08:18.003Z

Canonical page: https://altss.com/profile/the-tautona-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology